Searched for
NOVARTIS SHARE PRICE
Global Market: European stocks subdued as oil surge fuels inflation, ECB rate hike betsEuropean shares were subdued on Monday as rising oil prices sparked by US-Iran tensions renewed inflation fears. Investors are closely moni...- Sun Pharma among 9 pharmaceutical firms to lower drug prices for Americans, Trump saysNine pharmaceutical firms reached deals with the Trump administration for lower drug prices. These agreements expand the total number of co...
- Mark Cuban’s ‘beyond incredible’ gesture wins hearts after heart transplant survivor faces $1,000 bill for vital medicineAfter undergoing a heart transplant, a survivor encountered steep increases in medication costs, initially losing her insurance coverage on...
- Novartis India shares soar 20% as Swiss parent plans full exit in Rs 1,446 crore dealNovartis India shares surged nearly 18% after its Swiss parent announced the sale of its 70.68% stake for approximately Rs 1,446 crore. A c...
- Market volatility derails Novartis' plan to sell stake in its India armNovartis AG's plan to sell its 70.68% stake in Novartis India faces challenges due to market volatility impacting valuation. Despite strate...
- Novartis puts its India-listed entity for up for saleThe strategic review will include an assessment of the 70.68% shareholding of Novartis AG in Novartis India. Novartis said there is no assu...
- Novartis India Q1 net profit rises 43% to Rs 6 croreRevenue from operations stood at Rs 98.11 crore for the quarter under consideration. It was Rs 92.46 crore for the same period a year ago, ...
- Novartis India Q1 net profit up 3% at Rs 14.31 croreThe company had posted a net profit of Rs 13.87 crore for the corresponding period of the previous fiscal.
- Novartis bids $ 470 mn for US cancer diagnostic firmIt says the price represents a 39 per cent premium over Genoptix's share value on Dec. 13, 2010, when rumors of a sale sparked a price surg...
- Aventis to exit JV with Novartis, sell stake for about Rs 100crAventis has agreed to continue to provide certain utilities in services to the Ankleshwar plant of CBVPL for a period of 3 yrs from the dat...
- Novartis looks to buy out Alcon for $38.5 bnDrug maker Novartis AG said Monday it plans to take over Alcon Inc. by paying $38.5 billion for the 77 percent stake.
- Novartis raises stake in Indian arm to 76.42 pcSwiss drug maker Novartis AG has hiked its stake to 76.42 per cent in its Indian subsidiary Novartis India pursuant to the completion of op...
- FIs respond to Novartis’ open offerInstitutional shareholders have participated in a big way in Novartis AG’s open offer for its Indian subsidiary Novartis India, boosting th...
- Novartis hikes offer price for arm to Rs 450Novartis AG, the Swiss pharma giant, has increased the open offer price for its subsidiary Novartis India to Rs 450 from Rs 351 per share.
- Novartis soars 20 pc as Swiss parent sweetens offer priceSwiss drug firm Novartis AG sweetened its open offer price to Rs 450 a share for acquiring an additional 39 per cent stake in its Indian su...
- Novartis open offer for Indian arm to begin on May 20Swiss Drug maker Novartis AG's open offer for acquiring an additional 39 pr cent stake in its Indian subsidiary will begin on May 20.
- Novartis' open offer hangs in balanceThe fate of the open offer of Swiss pharma giant Novartis to scale up its stake in its Indian subsidiary Novartis India looks uncertain wit...
- Novartis open offer for Indian arm to begin on May 14Swiss drug maker Novartis AG's open offer for acquiring an additional 39 per cent stake in its Indian subsidiary will begin on May 14.
- Novartis ties up with USV to market Galvus in IndiaNovartis has tied up with leading healthcare company - USV - to market its anti-diabetic product Galvus.
- Novartis eyes share buy backsWhen asked whether Novartis was interested in buying U.S. biotechnology firm MedImmune , Vasella said biotech firms were "on our radar scre...
Load More
